8-K 1 a8-k.txt 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: August 3, 2000 (Date of earliest event reported) TREGA BIOSCIENCES, INC. (Exact name of registrant as specified in its charter) Delaware 0-27972 51-0336233 (State or other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification No.) 9880 Campus Point Drive, San Diego, CA 92121 (Address of principal executive offices) (Zip Code) (858) 410-6500 (Registrant's telephone number, including area code) ITEM 5. OTHER EVENTS Attached hereto as Exhibit 99.1 and incorporated by reference herein is financial information for Trega Biosciences, Inc. for the quarter ended June 30, 2000 and forward-looking statements relating to the second half of 2000 as presented in a press release of August 3, 2000. ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS (c) Exhibits 99.1 Financial information for Trega Biosciences, Inc. for the quarter ended June 30, 2000 and forward-looking statements relating to the second half of 2000. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TREGA BIOSCIENCES, INC. (Registrant) Date: August 4, 2000 By: /s/ MICHAEL G. GREY ------------------------------------- Michael G. Grey President and Chief Executive Officer